Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Chronic Lymphocytic Leukemia
100%
Von Willebrand Factor
100%
Von Willebrand Disease
100%
Antibody-mediated
28%
Hematological Malignancies
14%
Malignancy
14%
Bleeding
14%
Platelets
14%
Autoantibodies
14%
Malignant Cells
14%
Bleeding Disorders
14%
Lymphoproliferative Disorders
14%
Myeloproliferative Neoplasms
14%
Shear Stress
14%
Proteolysis
14%
Antibody Binding
14%
Difficult-to-treat
14%
Adult Case
14%
Circulating Immune Cells
14%
Congenital Deficiency
14%
Fatal Bleeding
14%
Functional Interference
14%
Von Willebrand Factor Concentrate
14%
Valvular Damage
14%
Non-active Site
14%
Low Activity
14%
Vascular Devices
14%
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
100%
Stem Cell Transplant
100%
Von Willebrand Factor
100%
Cancer
12%
Platelet
12%
Disease
12%
Hematologic Malignancy
12%
Bleeding Disorder
12%
Antigen Antibody Complex
12%
Vascular Device
12%
Protein Degradation
12%
Reticuloendothelial System
12%
Autoantibodies
12%
Pharmacology, Toxicology and Pharmaceutical Science
Syndrome
100%
Chronic Lymphatic Leukemia
100%
Von Willebrand Factor
100%
Hematologic Malignancy
12%
Bleeding Disorder
12%
Autoantibodies
12%
Biochemistry, Genetics and Molecular Biology
Stem Cell Transplant
100%
Von Willebrand Factor
100%
Active Site
12%
Absorption
12%
Shear Stress
12%
Antigen Antibody Complex
12%
Autoantibodies
12%
Platelet
12%
Proteolysis
12%
Neuroscience
Stem Cell
100%
Von Willebrand Factor
100%
Proteolysis
12%
Antigen Antibody Complex
12%
Autoantibodies
12%
Platelet
12%